Our experts

Eromona Whiskey is a Consultant Pharmacist at the Trust and an Honorary Clinical Lecturer at Kings College London Institute of Pharmaceutical Sciences. His research interest is the treatment of refractory psychotic disorders.

Education and Training

B.Pharm Hons, University of Nigeria, Nsukka School of Pharmacy, 1985

Selected publications

• Whiskey E, Wykes T, Duncan-McConnell D, Haworth E, Walsh N, Hastilow S. Continuation of clozapine treatment: practice makes perfect. Psychiatric Bulletin. 2003 Dec;27(6):211-3.
• Whiskey E, Taylor D. Restarting Clozapine after Neutropenia. CNS drugs. 2007 Jan 1;21(1):25-35.
• Whiskey E, Olofinjana O, Taylor D. The importance of the recognition of benign ethnic neutropenia in black patients during treatment with clozapine: case reports and database study. Journal of psychopharmacology. 2011 Jun;25(6):842-5.
• Whiskey E, Dzahini O, Ramsay R, O’Flynn D, Mijovic A, Gaughran F, MacCabe J, Shergill S, Taylor D. Need to bleed? Clozapine haematological monitoring approaches a time for change. International clinical psychopharmacology. 2019 Sep 1;34(5):264-8.
• Lowe P, Krivoy A, Porffy L, Henriksdottir E, Eromona W, Shergill SS. When the drugs don’t work: treatment-resistant schizophrenia, serotonin and serendipity. Therapeutic Advances in Psychopharmacology. 2018 Jan;8(1):63-70.